This is a community-generated profile. If you would like to claim it, please .
Deciphera Pharmaceuticals
Enabled by our proprietary kinase switch control inhibitor platform, we have built a diver201-500 EmployeesActively Hiring
- 4.5Work / Life BalanceEmployees rate Deciphera Pharmaceuticals 4.5/5 on Glassdoor for work / life balance
Deciphera Pharmaceuticals careers
Deciphera, a commercial biopharmaceutical company, is decoding cancer at the molecular level and leveraging its proprietary kinase switch control technology to develop therapies for hard-to-treat cancers. The Company has one FDA-approved product, QINLOCK, a broad-spectrum KIT and PDGFRα inhibitor, for the treatment of patients with fourth-line GIST and is using its platform to develop a diverse pipeline of drug candidates designed to improve outcomes for patients with cancer.
Associate Director, Commercial Finance
In office • Waltham
$176k – $215k1 week ago
Senior Program Manager, Program Leadership and Management
In office • Waltham
$143k – $197kSaranya Gomathi Babu
Detail-oriented and security-driven Cybersecurity Analyst with a solid foundation in threat detection, incident response, vulnerability management, and SIEM
Akil Amin
Senior IT Manager: Driving Business Resilience, Integrating Strategic Planning, Operations, Cybersecurity, and Leading Cross-Functional Teams to Operational Efficiency
Varun Virani
An Industrial engineer with a record of success in Supply Chain Analysis, Demand Planning, Production Planning and Continuous Improvement.
Total raised
$127M
Funded over
3 rounds
Latest round
Series C (Jun 2017)
